MedTrace Logo

The Effect of Momordica Charantia Supplementation on Blood Glucose Levels

NCT04090788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-10-12

No results posted yet for this study

Summary

The study is a randomized, cross-over, double blind, controlled trial in which study participants will receive two 4-week interventions with a washout period of 4 weeks between interventions. Study subjects will visit the research facility before and after each intervention period for a test day. In the third intervention week participants are provided with a 3-day controlled diet and glucose responses will be monitored via a continuous glucose monitoring device.

Conditions

  • Glucose Intolerance

Interventions

DIETARY_SUPPLEMENT

dried bitter-gourd supplements

intervention with 2.4g/d dried bitter-gourd supplements

DIETARY_SUPPLEMENT

dried cucumber supplements

reference intervention with 2.4g/d dried cucumber supplements

Sponsors & Collaborators

  • Wageningen University and Research

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-17
Primary Completion
2019-12-24
Completion
2019-12-25

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04090788 on ClinicalTrials.gov